High target disease prevalence, product launches, and increasing strategic developments such as partnerships and agreements are driving the market for cell therapy.
Market Size – USD 5.79 Billion in
2019, Market Growth - CAGR of 5.6%, Market Trends – Advancement in technology.
The global Cell Therapy Market is forecast to reach USD 8.75 Billion by 2027, according
to a new report by Reports and Data. The market for cell therapy is observing a
high demand due to the rise in the number of clinical trials across the world.
These therapies are used in regenerative medicine, especially for degenerative
and immunogenic pathologies. However, the applications of cell therapy in
oncology will experience higher growth, owing to a large number of pipeline
projects for the treatment of tumors or cancer.
The inception of effective guidelines
for cell therapy manufacturing, the development of advanced genomic analysis
techniques, a vast number of research by cancer societies, and proven
effectiveness of transplants are some of the primary growth stimulants for the
market. Certain pharmacological and manufacturing issues and regulatory hurdles
are restricting the growth of the market.
Ask for
Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/3269
The Japanese government has
recognized cell therapy and regenerative medicine as a major donor to the
country’s economic growth. This has influenced the attention of global market
players towards the Asian market, thereby fostering marketing operations in the
region.
Many deals and new companies are
coming up to boost the research in cell therapy. UK Biotech startup Bit Bio
received a €36.9 million Series A funding, in June 2020, to boost the manufacturing
efficiency of human cells for application in cell therapy and drug discovery.
The COVID-19 impact:
The market for cell therapy will witness a surge in demand as
biopharmaceutical innovators are in the front line for the human response to
the global COVID-19 pandemic. A remarkable number of biotech firms are in the
midst of the race to scrutinize the virus's genome and are trying to develop a
viable vaccine. These companies are investigating the virus at an unparalleled
rate, and considerable funds are being invested into the research. The
companies are in trial, and the private and public sectors are working
continuously for the development of the vaccine.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3269
Further key findings from the report
suggest
·
Allogeneic Stem Cell Therapy
dominated the therapy type segment. The segment is advantageous as they produce
their own immune stem cells, which can kill cancer cells that remain even after
high-dose cytotoxic drugs treatment. The patients those have a high risk of
relapse after successful treatment of chemotherapy are recommended allogeneic
transplants. The rising cases of cancer relapse have fueled the demand for the
segment.
·
Stem cell banking is gaining
popularity from the initiatives taken by the government. The number of stem
cell banks are increasing in developing nations, which is further propelling
market growth. Also, increasing awareness regarding the storage of stem cells
has had a positive effect on the market. The market is still at a nascent
stage, but it holds potential in both therapeutic and diagnosis fields.
·
Hospitals and clinics are forecasted
to grow at a significant CAGR of 5.8% during the forecast period. The lucrative
growth in the segment is due to the increase in the number of pipeline projects
over the past few years. As per the Cancer Research Institute (CRI), the number
of projects rose from 753 in 2018 to 1,011 in 2019.
·
Cell therapy has been observed to
induce profound healing activity in animals with different forms of autoimmune
disorders. Besides healing damaged tissues, it has the unique ability to
modulate the immune system while preserving its ability to fight off disease.
·
North America is anticipated to
account for a significant share of the global cell therapy market. The United
States will be the major contributor and is expected to witness high growth
owing to the huge amount of funding by the government and private firms for
clinical trials.
·
Key participants include JCR
Pharmaceuticals Co. Ltd., Fibrocell Science, Inc., Kolon TissueGene, Inc.,
Osiris Therapeutics, Inc., PHARMICELL Co., Ltd., MEDIPOST, Stemedica Cell
Technologies, Inc., Cells for Cells, Vericel Corporation, and ANTEROGEN Co.,
Ltd., among others.
Request a customization of the report @
https://www.reportsanddata.com/request-customization-form/3269
For the purpose of this report,
Reports and Data have segmented the global Cell Therapy Market on the basis of
therapy type, therapeutic area, cell type, end-user, and region:
Therapy Type Outlook (Revenue, USD
Billion; 2017-2027)
·
Allogenic Stem Cell Therapy
·
Autologous Stem Cell Therapy
Therapeutic Area Outlook (Revenue,
USD Billion; 2017-2027)
·
Malignancies
·
Autoimmune Disorders
·
Musculoskeletal Disorders
·
Dermatology
·
Others
Cell Type Outlook (Revenue, USD
Billion; 2017-2027)
·
Stem Cells
·
Non-Stem Cells
End-User Outlook (Revenue, USD Billion;
2017-2027)
·
Hospitals & Clinics
·
Academic & Research Institutes
Regional Outlook (Revenue, USD
Billion; 2017-2027)
·
North America
o
U.S
o
Canada
·
Europe
o
Germany
o
U.K
o
France
o
BENELUX
o
Rest of Europe
·
Asia Pacific
o
China
o
Japan
o
South Korea
o
Rest of APAC
·
Latin America
o
Brazil
o
Rest of LATAM
·
MEA
o
Saudi Arabia
o
UAE
o
Rest of MEA
To know more about the report @ https://www.reportsanddata.com/report-detail/cell-therapy-market
Key Highlights of the report:
·
The
report provides an extensive evaluation of the global Cell Therapy Market including
the recent trends and emerging trends of the industry.
·
A
thorough qualitative and quantitative analysis of the market to offer an accurate
insight of the industry to assist the readers and investor capitalize on the
current and emerging opportunities of the market.
·
Extensive
analysis of the product portfolio, application spectrum, and end-users to
provide in-depth understanding to the readers.
·
Thorough
profiling of the leading players of the industry and their expansion
strategies.
·
SWOT
analysis and Porter’s Five Forces Analysis along with feasibility analysis and
investment return analysis
·
Comprehensive
study of recent developments in the market such as product launches, mergers,
acquisitions, collaborations, joint ventures, and partnerships among others.
In
conclusion, the report is constructed through a thorough primary and secondary
research with the insightful data of the market validated from the industry
experts and professionals. The study is an extensive document of the key
aspects of the markets including trends, segmentation, growth prospects,
opportunities, challenges, and competitive analysis. It also strives to offer
the key players and novice companies key-pointers to strengthen their presence
in the global market.
No comments:
Post a Comment